These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Malignant tumors under immunosuppression, new problem in transplant recipients]. Enderlin F; Guisan Y Schweiz Rundsch Med Prax; 1973 Aug; 62(34):1031-5. PubMed ID: 4582307 [No Abstract] [Full Text] [Related]
29. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Qunibi WY; Barri Y; Alfurayh O; Almeshari K; Khan B; Taher S; Sheth K Transplant Proc; 1993 Feb; 25(1 Pt 2):1402-5. PubMed ID: 8442155 [No Abstract] [Full Text] [Related]
30. Predialysis immunosuppression is an independent risk factor for some cancers in renal transplantation. Hibberd AD; Trevillian PR; Wlodarzcyk JH; Gillies AH; Stein AM; Sheil AG; Disney AP Transplant Proc; 2001; 33(1-2):1846-7. PubMed ID: 11267538 [No Abstract] [Full Text] [Related]
31. [Lymphoma with bladder involvement and renal transplantation]. Chebil M; Martin X; Friaa S; Ezzeddine W; Garnier JL; Desmettre O; Maréchal JM; Gelet A; Dubernard JM Prog Urol; 1995 Feb; 5(1):102-5. PubMed ID: 7719353 [TBL] [Abstract][Full Text] [Related]
32. Can immune monitoring help to minimize immunosuppression in kidney transplantation? Ashton-Chess J; Giral M; Soulillou JP; Brouard S Transpl Int; 2009 Jan; 22(1):110-9. PubMed ID: 18764832 [TBL] [Abstract][Full Text] [Related]
34. Incidence of cancer after immunosuppressive treatment for heart transplantation. Ippoliti G; Rinaldi M; Pellegrini C; Viganò M Crit Rev Oncol Hematol; 2005 Oct; 56(1):101-13. PubMed ID: 15979322 [TBL] [Abstract][Full Text] [Related]
35. Verrucous carcinoma in a reanl transplant patient after long-term immunosuppression. Turner JE; Hodge SJ; Callen JP Arch Dermatol; 1980 Sep; 116(9):1074-6. PubMed ID: 6998379 [No Abstract] [Full Text] [Related]
36. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy. Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008 [TBL] [Abstract][Full Text] [Related]
37. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune. Cockburn I Transplant Proc; 1987 Feb; 19(1 Pt 2):1804-7. PubMed ID: 3547886 [No Abstract] [Full Text] [Related]
38. An update in transplant immunosuppressive therapy. Thursby MA; Yango AF; Gohh RY Med Health R I; 2002 Apr; 85(4):131-3. PubMed ID: 11989401 [No Abstract] [Full Text] [Related]
39. Renal transplantation, immunosuppression and the skin: an update. Moloney FJ; de Freitas D; Conlon PJ; Murphy GM Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217 [TBL] [Abstract][Full Text] [Related]